SCHEMBL7743946

SCHEMBL7743946

CC(C)C(CO)(CO)COCC(CO)(CO)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9531657 0.81 DPP4 (0.31) DPP4
SCHEMBL6913846 0.78 DPP4 (0.40) DPP4
SCHEMBL11654283 0.75
SCHEMBL23250929 0.74 TSHR (0.43)
SCHEMBL21536769 0.73
SCHEMBL15643515 0.72 DPP4 (0.30) DPP4
SCHEMBL11654287 0.71 DPP4 (0.35) DPP4
SCHEMBL20224768 0.71 DPP4 (0.35) DPP4
SCHEMBL765917 0.71 DPP4 (0.35) DPP4
SCHEMBL14891479 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077287-B1 EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES PFIZER IRELAND PHARMACEUTICALS UNLIMITED COMPANY (IE) 2025-11-19 EP disclosed
US-20230090609-A1 Efficient Process For Making 6-Carboxy Benzoxazole Derivatives PFIZER IRELAND PHARMACEUTICALS (US) 2023-03-23 US disclosed
EP-4077287-A1 EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES Pfizer Ireland Pharmaceuticals (IE) 2022-10-26 EP disclosed
WO-2021124158-A1 EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES PFIZER IRELAND PHARMACEUTICALS (IE) 2021-06-24 WO disclosed
WO-2001014300-A1 PROCESS FOR PRODUCTION OF AN ETHERALCOHOL PERSTORP AB (SE) 2001-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230090609-A1 Efficient Process For Making 6-Carboxy Benzoxazole Derivatives CYP2B6, CYP4X1, CYP2C9 DPP4 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.